Flow cytometry data showed that FITC-labeled siRNA was successfully transfected into B-CPAP cells with 87.7% efficiency compared to the untransfected control group, demonstrating the effectiveness of Lipofectamine in delivering siRNA to B-CPAP cancer cells (Fig. 2). This evidence concerns the gene CPAP and cancer.